Anticoagulation for stroke prevention in atrial fibrillation: is gender important?
Open Access
- 4 July 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 27 (16) , 1893-1894
- https://doi.org/10.1093/eurheartj/ehl140
Abstract
The presence of atrial fibrillation (AF) confers a five-fold increased risk of stroke, a figure that may rise to as high as 17 times in the presence of structural heart disease, in particular mitral stenosis. It is estimated that 15% of all strokes may be directly attributable to AF, but of greater concern is that when patients with AF have a stroke, they have a much worse outcome. Being an increasingly more prevalent arrhythmia and given the increasing mean age of the general population, AF presents a significant economic burden.Keywords
This publication has 9 references indexed in Scilit:
- Ximelagatran: An eulogyThrombosis Research, 2006
- Management of atrial fibrillationHeart, 2006
- Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trialsEuropean Heart Journal, 2006
- Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial FibrillationCirculation, 2005
- A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the CommunityJAMA, 2003
- A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley studyPublished by Elsevier ,2002
- Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial FibrillationStroke, 1999
- Physician variation in the management of patients with atrial fibrillation.Heart, 1996
- Independent Risk Factors for Atrial Fibrillation in a Population-Based CohortJAMA, 1994